Selectis Health (GBCS) Equity Average (2011 - 2025)

Selectis Health has disclosed Equity Average across 15 years of filings, most recently posting -$5.9 million for Q4 2025.

• Equity Average for Q4 2025 came in at -$5.9 million, down 15.8% year-over-year; the trailing twelve-month figure through Dec 2025 was -$5.9 million (down 15.8% YoY), and the FY2025 annual result was -$5.8 million, down 38.77% from the prior year.
• Equity Average came in at -$5.9 million for Q4 2025 at Selectis Health, up from -$6.0 million in the prior quarter.
• In the past five years, Equity Average ranged from a high of $3.9 million in Q2 2023 to a low of -$6.2 million in Q2 2025.
• The 5-year median for Equity Average is $1.9 million (2022), against an average of -$355456.9.
• Across the five-year window, Equity Average soared 726.74% in 2021 and slumped 347.92% in 2024, its largest moves.
• Selectis Health's Equity Average stood at $3.2 million in 2021, then sank by 36.41% to $2.1 million in 2022, then plunged by 155.37% to -$1.1 million in 2023, then plunged by 347.92% to -$5.1 million in 2024, then fell by 15.8% to -$5.9 million in 2025.
• The last three Equity Average figures came in at -$5.9 million (Q4 2025), -$6.0 million (Q3 2025), and -$6.2 million (Q2 2025), per Business Quant data.